Mack,GS

BioInfoBank Library

News Reports Papers Users Groups Forums Jobs Meetings Projects E-learning

author name	recommending	commenting	favorite	papers	recom.	cited
Mack GS (G S)	0	0	0	5	0	0	[Update] [Favorite][Unfavor]
Mack GS (George S)	0	0	0	28	0	81	[Update] [Favorite][Unfavor]

Latest Paper:

Nat Biotechnol. 2011 May ;29 (5):459 21552247

go to Publisher

go to Pubmed

go to Scholar

go to Google

show EndNote Citation

show BibTex Citation

MicroRNA gets down to business.

Nat Biotechnol. 2011 Feb ;29 (2):95-7 21301419 Cit:1

go to Publisher

go to Pubmed

go to Scholar

go to Google

show EndNote Citation

show BibTex Citation

ReNeuron and StemCells get green light for neural stem cell trials.

Nat Biotechnol. 2010 Mar ;28 (3):214-29 20212481 Cit:3

go to Publisher

go to Pubmed

go to Scholar

go to Google

show EndNote Citation

show BibTex Citation

Lost in migration.

George S Mack, Andrew Marshall

George S. Mack is a freelance writer based in Columbia, South Carolina.

Nat Biotechnol. 2009 Oct ;27 (10):871-2 19816423

go to Publisher

go to Pubmed

go to Scholar

go to Google

show EndNote Citation

show BibTex Citation

Expanded access rules pose quandary for drug developers.

George S. Mack, Columbia, South Carolina. With additional reporting by Malorye Allison, Acton, Massachusetts.

Nat Biotechnol. 2009 Jun ;27 (6):494 19513035

go to Publisher

go to Pubmed

go to Scholar

go to Google

show EndNote Citation

show BibTex Citation

Mixed news for Avastin.

Nat Biotechnol. 2009 Feb ;27 (2):205 19204704

go to Publisher

go to Pubmed

go to Scholar

go to Google

show EndNote Citation

show BibTex Citation

Erratum: Profile: Alan Alda.

Nat Biotechnol. 2009 Feb ;27 (2):110-112 19204679 Cit:7

go to Publisher

go to Pubmed

go to Scholar

go to Google

show EndNote Citation

show BibTex Citation

FDA holds court on post hoc data linking KRAS status to drug response.

Columbia, South Carolina.

Nat Biotechnol. 2009 Feb ;27 (2):106-107 19204671 Cit:1

go to Publisher

go to Pubmed

go to Scholar

go to Google

show EndNote Citation

show BibTex Citation

Osiris seals billion-dollar deal with Genzyme for cell therapy.

Columbia, South Carolina.

Nat Biotechnol. 2008 Dec ;26 (12):1325 19060860 Cit:1

go to Publisher

go to Pubmed

go to Scholar

go to Google

show EndNote Citation

show BibTex Citation

Columbia, South Carolina.

Nat Biotechnol. 2008 Dec ;26 (12):1323 19060858

go to Publisher

go to Pubmed

go to Scholar

go to Google

show EndNote Citation

show BibTex Citation

Giants wrestle over ImClone.

Polish News

FP7 Partner

Add BioInfo.PL bioinformatics lab
to Your FP7 application

bioinfo.pl

2012-05-22 18:48:59 © BioInfoBank Institute